<sentence id="0">Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells .</sentence>
<sentence id="1">Binding of plasma Factor VII/VIIa to the tissue factor ( TF ) receptor initiates the coagulation protease cascades .</sentence>
<sentence id="2">TF expression by circulating monocytes is associated with thrombotic and inflammatory complications in a variety of diseases .</sentence>
<sentence id="3">Transcriptional activation of the human TF gene in monocytic cells exposed to bacterial lipopolysaccharide ( LPS ) is mediated by binding of c-Rel/p65 heterodimers to a kappa B site in the TF promoter .</sentence>
<sentence id="4">Here , we report that a family of anti-inflammatory agents , known as the salicylates , inhibited LPS induction of TF activity and TF gene transcription in human monocytes and monocytic THP-1 cells at clinically relevant doses .</sentence>
<sentence id="5">Furthermore , sodium salicylate blocked the LPS-induced proteolytic degradation of I kappa B alpha , which prevented the nuclear translocation of c-Rel/p65 heterodimers .</sentence>
<sentence id="6">In contrast , two other nonsteroidal anti-inflammatory drugs , ibuprofen and indomethacin , did <scope type="neg" id="0"><cue type="neg" id="0">not</cue> inhibit LPS induction of the TF gene</scope> .</sentence>
<sentence id="7">These results <scope type="spec" id="1"> <cue type="spec" id="1">indicated that</cue> salicylates inhibited LPS induction of TF gene transcription in monocytic cells by preventing nuclear translocation of c-Rel/p65 heterodimers</scope> .</sentence>
<sentence id="8"><scope type="spec" id="2"> The clinical benefits of salicylates in the treatment of several diseases , including atherosclerosis and rheumatoid arthritis , <cue type="spec" id="2">may</cue> be related to their ability to reduce monocyte gene expression</scope> .</sentence>